TTH.CA Profile & Description — Transition Therapeutics Inc.
Transition Therapeutics is a biopharmaceutical company engaged in developing therapeutics for disease indications. Co.'s technologies are focused on the treatment of Alzhemier's disease and diabetes. Co.'s products include ELND005 (AZD-103) for the treatment of Alzheimer's disease; TT-301 and TT-302 which may have a therapeutic effect on diseases including arthritis, Alzheimer's disease, traumatic brain injury, intracerebral haemorrhage, and others; and TT401/402 for the treatment of diabetes.